Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus
Oral Diseases Jan 06, 2018
Arduino PG, et al. - The authors aimed to investigate the efficacy of using clobetasol propionate 0.05% in the treatment of symptomatic oral lichen planus (OLP). To improve symptoms in subjects affected by atrophic erosive oral lesions, clobetasol at this dosage was found to be more effective than placebo.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries